Towards Healthcare
Chronic Lower Back Pain Market Size and Companies Report by 2033

Chronic Lower Back Pain Market Size Envisioned at USD 6.12 Billion by 2033

The report covers Chronic Lower Back Pain Market Manufacturers and Segments Outlook starting with drug classes such as Non-steroidal Anti-inflammatory Drugs, Antidepressants, Analgesics, Opioids and others. It examines administration routes including oral, topical and others. The report assesses distribution channels, highlighting the roles of hospital pharmacies and retail & online pharmacies. Geographically, the analysis spans North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Chronic Lower Back Pain Market Assessment

  • Overview
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies
  • Global Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

North America Chronic Lower Back Pain Market Assessment

  • Overview
  • North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • North America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Europe Chronic Lower Back Pain Market Assessment

  • Overview
  • Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Europe Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Asia Pacific Chronic Lower Back Pain Market Assessment

  • Overview
  • Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Asia Pacific Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Latin America Chronic Lower Back Pain Market Assessment

  • Overview
  • Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Latin America Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Middle East & Africa Chronic Lower Back Pain Market Assessment

  • Overview
  • Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Non-steroidal Anti-inflammatory Drugs
    • Antidepressants
    • Analgesic
    • Opioids
    • Others
  • Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Middle East & Africa Chronic Lower Back Pain Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail & Online Pharmacies

Company Profiles

  • SpineThera Inc. (U.S.)
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Johnson & Johnson Private Limited (U.S.)
  • Medtronic (Ireland)
  • Endo Pharmaceuticals Inc. (Ireland)
  • Sanofi (France)
  • Merck & Co Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Vertebral Technologies, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Astellas Pharma Inc. (Japan)
  • CELGENE CORPORATION (U.S.)

Conclusion & Recommendations

  • Insight Code: 5156
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Physical therapy, home exercise, meditation, proper diet, modification of lifestyle, use of injectables and pharmacologic treatments.

Spine X-ray, MRI, CT scan, electromyography and other tests depending on the cause of the pain.

FDA, World Health Organization, Centers for Disease Control and Prevention, American Association of Neurological Surgeons, National Institute of Health and Bone and Joint Canada.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509